TopDollar Investing

[Carnivool]

EVIO Labs Prepared to Fund California Cannabis Laboratory Expansion

EVIO, Inc. (OTCQB: SGBYD) (EVIO or the Company) the nations leading provider of analytical laboratory cannabis testing, research science and advisory services, is pleased to announce that the Company has authorized the reduction of the Companys authorized outstanding shares from 1.01 Billion to 110 Million.

- 21.35 million shares outstanding
- 13.15 million controlled by Company officers with the majority of those shares held by company founders CEO Will Waldrop and COO Lori Glauser
- 7.2 million shares in the public float.